Joonsuk Park, MSc
Clinical Research Coordinator
Medicine
School of Medicine

Publications (2)

Top publication keywords:
CisplatinAntineoplastic Combined Chemotherapy ProtocolsTumor MicroenvironmentCarcinoma, Pancreatic DuctalAlbuminsDouble-Blind MethodHumansAdjuvants, ImmunologicDeoxycytidinePaclitaxelBiliary Tract NeoplasmsPancreatic Neoplasms

• Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
  Lancet (London, England) 2023 Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel …
• Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Tempero MA, Pelzer U, O'Reilly EM, Winter J, Oh DY, Li CP, Tortora G, Chang HM, Lopez CD, Bekaii-Saab T, Ko AH, Santoro A, Park JO, Noel MS, Frassineti GL, Shan YS, Dean A, Riess H, Van Cutsem E, …